Search Beyond News…

BASF urged to seize Evonik’s weakness via bold takeover bid

Executive summary: Handelsblatt published a commentary advocating for BASF to launch a takeover of Evonik, asserting the move is both bold and justified. Such a merger would reshape Europe's chemicals landscape, creating a larger entity better positioned to compete with US and Middle Eastern rivals.

Who is involved: BASF, Evonik, European chemical industry stakeholders, and potentially EU competition authorities.

Likely next: BASF may evaluate a formal offer; Evonik’s board and shareholders would assess any proposal; regulatory scrutiny would follow if transaction thresholds are met.

A Handelsblatt commentary has argued that BASF should take advantage of Evikon’s current weakness and launch a bold takeover bid, describing such a move as both courageous and correct. The piece notes that the suggestion comes amid rising competitive pressure from U.S. and Gulf‑based chemical producers and frames the potential deal as a way for European chemical consolidation to be driven by domestic players rather than foreign actors. While the commentary does not provide any concrete terms, timelines or board approvals, the mere prospect of a BASF‑Evonik combination has already prompted a noticeable reaction in the share prices of both companies, indicating that investors are sensitive to the idea of a major reshaping of the German chemical sector. If BASF were to pursue the acquisition, the implied rationale would be to achieve greater scale, potentially unlock cost synergies across research, production and logistics, and strengthen its position against low‑cost overseas competitors. However, any such transaction would also invite scrutiny from antitrust authorities given the combined market share the two firms hold in specialty chemicals, performance materials and agricultural solutions. The lack of disclosed financial details means that the potential impact on leverage, dividend policy or integration costs remains uncertain at this stage. In the near term, market participants are likely to watch for any formal statements from BASF’s management or board regarding due‑diligence activities, as well as for regulatory signals that could affect the feasibility of a deal. Until concrete steps are taken, the discussion remains speculative, but the heightened attention underscores the strategic importance of scale and competitiveness in the European chemicals landscape.

What's next — scenarios

BASF Initiates Exploratory M&A Talks (20%)

Chemical suppliers must prepare for significant portfolio rationalization and antitrust compliance reviews over the next 12 months.

Evonik Restructures Independently (50%)

Competitive pressure in the European specialty chemicals market will persist, forcing smaller players to cut costs rather than consolidate.

Foreign Private Equity Intervenes (30%)

European chemical assets face foreign acquisition, shifting competitive dynamics and supply chain access for industrial buyers.

What to watch

Timeline

Analysis — what this means

Sectors affected

Key entities

Sources

Related cases

Browse the full archive →